@article{7220d592b1444a6985af3f71968c209d,
title = "Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling",
keywords = "anticoagulation, atrial fibrillation, renal function",
author = "{For the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators} and Pokorney, {Sean D.} and Peter Shrader and Laine Thomas and Fonarow, {Gregg C.} and Kowey, {Peter R.} and Singer, {Daniel E.} and Jack Ansell and Gersh, {Bernard J.} and Mahaffey, {Kenneth W.} and Hylek, {Elaine M.} and Go, {Alan S.} and Piccini, {Jonathan P.} and Peterson, {Eric D.}",
year = "2016",
month = oct,
day = "11",
doi = "10.1161/CIRCULATIONAHA.116.024333",
language = "English (US)",
volume = "134",
pages = "1122--1124",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "15",
}